Shares of MicroPort Scientific (00853.HK) plummeted 5.42% in Friday's pre-market trading session following the company's announcement of expected financial results for the first half of 2025. The medical device manufacturer's stock took a hit as investors reacted to projections of a significant loss and a slight decline in revenue.

According to the company's statement, MicroPort Scientific anticipates recording a loss of no more than US$110 million for the first half of the year. This news comes as a blow to investors who may have been hoping for improved financial performance. Adding to the bearish sentiment, the company also revealed that its revenue is expected to decrease by no more than 4% year-on-year for the same period.

While the company did not provide specific reasons for the projected loss and revenue decline, these figures suggest ongoing challenges in MicroPort's operating environment. The medical device industry has been facing various headwinds, including supply chain disruptions and fluctuating demand due to the global economic situation. Investors will likely be looking for more detailed explanations and future guidance when the company releases its full interim results.